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Abstract 
Fzd4 is a receptor for Wnt proteins, belonging to the 
frizzled receptors family. Its stimulation can activate 
both Wnt/β-catenin canonical and Wnt/Ca2+ non 
canonical pathways. This receptor plays an 
important role in the development processes, in 
particular in the retinal vascularization: it binds the 
Norrin ligand, a Wnt-unrelated growth factor, and 
activates β-catenin signalling pathway. Mutations of 
FZD4 gene are associated with Familial Exudative 
Vitreoretinopathy (FEVR). Recently dysregulation 
of FZD4 expression has been reported in different 
type of cancers, but FZD4 contribution in tumor 
pathogenesis and progression is still not entirely 
elucidated. 
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Identity 
Other names 
Frizzled 4, Seven Transmembrane Spanning 
Receptor, Frizzled (Drosophila) homology 4, 
Frizzled homolog 4 (Drosophila), CD344 Antigen, 
FEVR, Fz-4, FZD4, Wnt receptor Frizzled -4, hFz4 
HGNC (Hugo) 
FZD4 
Location 
11q14.2 
Location (base pair) 
Starts at 86945675 and ends at 86955398 bp from 
pter ( according to hg38-Dec_2013) 
DNA/RNA 
Figure 1:  Schematic representation of FZD4 gene 
that contains a total of two exons and FZD4 
transcript. 
Description 
DNA size: 9.71kb encoding two exons. This gene 
has one transcript (splice variant), 82 orthologues, 12 
paralogues (www.emsable.org). Sagara et al., 
reported a splice variant of FZD4 gene which they 
called FZD4SA, it retains intronic sequence and 
encodes shorter isoform of only 125 aa. However, its 
expression is not supported by other experimental 
evidences. 
Transcription 
The FZD4 mRNA transcript is 7383 bp. FZD4-001 
ENST00000531380.1: mRNA7383 bp, protein 537 
aa. 
Protein 
FZD4 (frizzled class receptor 4)  
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Description 
The gene FZD4 encodes a 537 aa protein with a 
molecular weight of 59 kDa. FZD4 is a member of 
the seven transmembrane receptor family consist of 
10 receptors that are activated by Wnt family of lipo-
glycoproteins. The Wnt/ FZD signaling is involved 
in a variety of biological processes and its 
dysregulation have been implicated in cancer 
development. FZD4 protein contains the N-terminal 
signal peptide (aa 1-36) that assurances proper 
membrane insertion of the protein, an extracellular 
cysteine rich domain (CRD; aa 40-161), which 
creates the binding site for WNT ligands, a seven-
pass transmembrane domain (aa 161-221) that gives 
rise to three intracellular loops, three extracellular 
loops and a C- terminal domain (aa 221-537). The 
CRD domain is necessary to bind WNT ligands or 
Norrin ligand leading to initiation of distinct 
downstream signaling pathways. (Schulte G., 2010). 
 
Expression 
In human, FZD4 is a ubiquitous protein. It is 
expressed in brain, ovary, liver, pancreas, brain, 
colon, heart, skeletal muscle, endothelial cells, 
endometrium, bone marrow, prostate, spleen, breast 
(www.ncbi.nlm.nih.gov). 
 
Figure 3:  Visualization of FZD4/WNT10B interaction in MCF7 adherent (top) and tumorsphere (bottom) by 
proximity ligation assay (Lazzaroni et al.,2016). 
 
Localisation 
FZD4 is localized on the plasma membrane surface. 
It can be internalized through both constitutive and 
agonist dependent endocytosis in response to Wnt5a 
stimulation (Chen W. et al., 2003). 
FZD4 (frizzled class receptor 4)  
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Function 
FZD4 is a member of Frizzled gene family involved 
in neuronal, follicle, cardiomyocyte and retinal 
vascular development, likewise its dysregulated 
expression lead to cancer and other diseases. 
Depending on the cellular contest, FZD4 interacts 
with different WNT ligands, leading to the activation 
of Wnt/β catenin signaling and sometimes non 
canonical Wnt/Ca2+ signaling. Wnt/β catenin 
signaling is activated when WNT ligands bind CDR 
FZD/Low-density lipoprotein receptor-related 
protein5/6 ( LRP5/ LRP6) complex, in this case 
CTNNB1 (β-catenin) degradation complex becomes 
inactivated, resulting in stabilization of β-catenin 
that can translocate in the nucleus, where it interacts 
with LEF1 (TCF/LEF) transcription factor, inducing 
the transcription of target genes (Clevers H., 2006). 
Recently, WNT10B/FZD4 interaction in the MCF7 
breast cancer cell line suggests an autocrine 
activation of Wnt signalling in this cell line model 
(Lazzaroni F. et al, 2016). In melanoma FZD4 binds 
WNT5A and stimulates tumor invasion through 
activation of βcatenin signaling (Grossman A. et al., 
2013), while in acute myeloid leukemia the 
interaction between WNT3A and FZD4 induce 
higher resistance against apoptosis (Tickenbrock L. 
et al., 2008). WNT2, WNT5A/ WNT5B and WNT11 
via FZD4 and FZD6 induced non canonical Wnt 
signaling activation that regulates cardiomyocite 
differentiation (Mazzotta S. et al., 2016) 
FZD4 is also the only FZD family member that binds 
selectively a growth factor called NDP (Norrin) and 
regulates endothelial cells growth during retinal 
vascular development. In retina, the binding of 
Norrin with FZD4 conjugated with LRP5 co-
receptor and protein TSPAN12 (Tetraspanin-12), 
results in activation of βcatenin signalling (Schulte 
G., 2010), alteration in one of this gene is associated 
with Familial Exudative Vitreoretinopathy. 
Homology 
The FZD4 gene is conserved in chimpanzee, mouse, 
Rhesus monkey, dog, cow, rat, chicken, zebrafish 
and frog. 
Mutations 
Germinal 
Several types of mutations (missense, nonsense, 
small deletions) have been reported for the human 
FZD4 gene and are related to the familial exudative 
vitreoretinopathy (FEVR). Among these mutations, 
different heterozygous substitutions have been 
reported: M342V, W335C, R417, I256V, P33S, 
G36N, H69Y, M105T, M105V, C181R, C204R, 
C204Y, C45Y, Y58C, W226X, and G488D (Zhang 
K. et al., 2011; Kondo H. et al. 2003; Quin et al., 
2005) It  has also been described a loss of function 
mutation of FZD4 with nucleotides 1479-1484 
deletion in two cases of FEVR, resulting in the 
lacking of met493 and trp494 that leads to a 
frameshift and creates a stop codon at residue 533 
(Robitaille J. et al.,2002). 
Implicated in 
Familial Exudative Vitreoretinopathy 
(FEVR) 
Familial Exudative Vitreoretinopathy (FEVR) is a 
hereditary ocular disorder characterized by 
incomplete development of the retinal vasculature.  
 
It is possible to distinguish two forms of FEVR: one 
with dominant autosomal inheritance and one with 
X-linked recessive inheritance (Gilmour DF., 2015).  
 
Autosomal inheritance has been associated with 
mutation of FZD4, LRP5 or Tetraspanin 12 
(TSPAN12) genes, while X-linked recessive 
inheritance is due to mutation of Norrin gene (NPD) 
that it is also involved in other ocular disease.  
 
Several FZD4 mutations were connected with 
FEVR, many of which were found in the 
extracellular portion of the protein. Kaykas et al., 
have shown how some FZD4 mutations in FEVR 
lead to the retention of mutated protein within the 
endoplasmic reticulum (ER), where it is recognized 
by endoplasmic-reticulum-associated protein 
degradation (ERAD) and degraded, not allowing its 
exposure on the plasma membrane. They also 
demonstrated that oligomerization of mutants and 
wild-type FZD4 in the ER reduces the FZD4 
function by preventing a sufficient amount of FZD4 
from reaching the cell membrane and inhibits its 
FZD4 (frizzled class receptor 4)  
 
Atlas Genet Cytogenet Oncol Haematol. 2018; 22(8) 320 
 
signaling. This dominant-negative effect can partly 
explain the pathological mechanism that causes the 
disease phenotype, in patients with heterozygous 
FZD4 mutations. Mutations that do not cause 
retention in ER of mutated protein, induce a 
conformational modification of the CRD FZD4 that 
doesn't permit the biding to its ligands or 
downstream targets. 
Acute myeloid leukemia (AML) 
It was demonstrated that FZD4 represents one of the 
mechanism of canonical or non canonical Wnt 
signaling activation in the pathogenesis of AML. 
Recently microarray analysis confirmed a higher 
expression of FZD4 in primary AML blast cells. 
(Beghini A. et al., 2012).  
 
Tickenbrock, A. et al, also showed FZD4 
overexpression in primary AML blasts, both in the 
presence or absence of FLT3 mutations. They also 
showed a canonical Wnt pathway activation due at 
specific WNT3A/FZD4 interaction, that leads to the 
stabilization of β-catenin and induces higher 
resistance against apoptosis. It was observed an 
involvement of FZD4 in differentiation of AML cell 
line mediated by 6-benzylthioinosine (6-BT) 
treatment. 6-BT treatment results in downregulation 
of canonical Wnt molecules and up-regulation of 
transcriptional level of the non canonical Wnt ligand 
Wnt5a and receptors FZD2, FZD4, FZD5, resulting 
in activation of Wnt/Ca2+ pathway ( Zang S. et al., 
2014). 
Non small cell lung cancer (NSCLC) 
Recently several studies have reported that single 
nucleotide polymorphisms (SNPs) of FZD4 gene can 
influence recurrence and survival of early stage 
NSCLC patients treated with only surgery or in 
combination with chemotherapy.  
 
miR-related SNP (rs713065) in the 3?UTR region of 
FZD4 gene is associated with decreased risk of death 
in early stage NSCLC patients treated with only 
surgery, while it is related to increased risk of death 
in patients treated with surgery plus chemotherapy 
(Pu X. et al., 2013). This FZD4-miR-SNP 
specifically interacts with MIR204 which acts as a 
tumor suppressor and inhibits the expression of 
FZD4 and transduction of Wnt/βcatenin signalling 
(Lin J. et al, 2017).) This FZD4-miR-SNP 
specifically interacts with miR-204 which acts as a 
tumor suppressor and inhibits the expression of 
FZD4 and transduction of Wnt/βcatenin signalling 
(Lin J. et al, 2017).  
 
Coscio A. et al, demonstrated that miR-SNP 
(rs10898564) of FZD4 is most significantly 
associated with increased recurrence and death risk 
in NSCLC patients treated with only surgery but not 
in patients treated with surgery and chemotherapy. 
These reports suggest a potential role of FZD4-SNPs 
as predictive biomarkers for both recurrence and 
survival in early stage NSCLC patients. 
Prostate cancer 
In prostate cancer cells have been shown activation 
of Wnt signalling through FZD4 leading to 
epithelial-to-mesenchymal transition (EMT) and 
loss of cell adhesion (Gupta S. et al., 2010; Acevedo 
VD et al., 2007). 
Breast cancer 
Recently Lazzaroni F. et al. evidenced an autocrine 
activation of Wnt signalling in breast cancer cell line 
model. In MCF7 cell line model they identified the 
WNT10B/FZD4 interacting complex using the in 
situ proximity ligation assay and a dose dependent 
reduction of WNT10B/FZD4 complex after the 
treatment with pharmacological inhibitor of 
porcupine, a membrane-bound acyltransferase that is 
essential to the production of Wnt proteins. 
Liver cancer 
It was revealed that Let7b microRNA inhibit Wnt/β-
catenin signaling pathway via downregulation of 
FZD4 in liver cancer cell, resulting in a reduction of 
proliferation, invasion, migration of liver cancer 
cells and reduction in the amount of cancer stem cells 
in liver (Cai H.et al 2017). 
Glioblastoma 
Microarray analysis in U87R4 invasive glioblastoma 
cell line reported an overexpression of FZD4, which 
actives Wnt/β catenin signalling pathway and 
promotes stemness and invasiveness of glioblastoma 
cells. (Jin X. et al. 2011). 
Medulloblastoma 
Recently evidences showed an involvement of 
Norrin/FZD4 signaling pathway in the cerebellar 
tumor medulloblastoma (MB) initiation. In this 
tumor, Norrin/FZD4 pathway acts as anti-tumor 
signal in the preneoplastic niche, in fact loss of 
function of Norrin/FZD4 signaling in the 
endothelian cells promotes the formation of 
preneoplastic lesion of MB and their progression to 
malignancies (Bassett E. et al., 2016). 
Bladder cancer 
FZD4 is a target of miR-493 in the bladder cancer. It 
was observed a down-regulated expression of miR-
493 in the bladder cancer tissue in comparison with 
normal bladder tissue. MIR493 transfection in the 
T24 or J82 bladder cancer cell line inhibits FZD4 and 
Rho4 expression, resulting in the inhibition of cell 
motility and migration  
 
These results, suggested that miR-493 represent a 
new tumor suppressor in the bladder cancer (Ueno 
K. et al., 2012). 
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Melanoma 
It was reported that in melanoma cells Wnt 
signalling activation through FZD4 promotes tumor 
cell invasion and metastasis. WNT5a binds 
FZD4/LRP6 receptor complex and actives the 
guanosine triphosphatase adenosine diphosphate 
ribosylation factor 6 ( ARF6), leading to the 
disruption of N-cadherin-βcatenin complex and 
accumulation of nuclear βcatenin, which increases 
the transcription of its target genes and stimulates 
melanoma invasion (Grossman A. et al., 2013) 
Chronic Myeloid Leukemia 
Agarwal P. et al., revealed a role of FZD4 in Wnt-
mediated regulation of CML progenitor growth and 
their resistance to tyrosine kinase inhibitor (TKI) 
treatment. Silencing of FZD4 expression in 
combination with Nilotinib (NIL) treatment reduces 
Wnt signalling activation and the colony forming 
capacity of CML cells. 
Colorectal cancer 
Expression of FZD4 in colorectal cancer and its 
binding with the Norrin ligand, produced by the 
same cells and endothelial tumor cells, activates β-
catenin signalling and regulates angiogenesis in the 
colorectal cancer microenvironment (K. Platinus et 
al. 2014). 
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